David Limauro, MD
Gastroenterology · Pittsburgh, PANPI 1891770467
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,059 of the $2,900 with a category attached, or 71.0%. 15 manufacturers reported payments, led by AbbVie at 34.4% of the total. Reporting peaked in 2022 at $1,126 and has fallen 74.9% since, to $282 in 2025.
Across 85 payments — averaging $34.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$998
- Biomerieux Inc$706
- Johnson & Johnson$392
- Phathom Pharmaceuticals, Inc.$145
- Bristol Myers Squibb$138
- Regeneron Healthcare Solutions, Inc.$110
- plus $411 from 9 others
Across 12 payments — averaging $20,741 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironwood Pharmaceuticals, Inc$249K
What the payments were for
- Consulting fees$70624%
- Food & beverage$2,05971%
- Education$1355%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $998 |
| Biomerieux Inc | 1 | $706 |
| Johnson & Johnson | 15 | $392 |
| Phathom Pharmaceuticals, Inc. | 4 | $145 |
| Bristol Myers Squibb | 7 | $138 |
| Regeneron Healthcare Solutions, Inc. | 4 | $110 |
| Pfizer | 3 | $75 |
| Braintree Laboratories, Inc. | 4 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $67 |
| Sanofi | 4 | $64 |
| Madrigal Pharmaceuticals | 1 | $34 |
| Lilly USA, LLC | 1 | $33 |
| Ardelyx, Inc. | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,900 in reported general payments places this provider in the 55th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 55 | $1,514,013 |
| RinvoqUpadacitinib | 13 | $95,170 |
| Humira(Cf) PenAdalimumab | 13 | $88,551 |
| Mesalamine | 44 | $36,595 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 418 | $29,383 |
| LinzessLinaclotide | 26 | $21,904 |
| Dexlansoprazole DrDexlansoprazole | 15 | $6,588 |
| Pantoprazole Sodium | 446 | $5,002 |
| Sucralfate | 24 | $4,151 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 21 | $3,334 |
| Mesalamine ErMesalamine | 16 | $3,153 |
| Colestipol Hcl | 17 | $2,422 |
| Omeprazole | 149 | $1,557 |
| Budesonide DrBudesonide | 12 | $1,231 |
| Sulfasalazine | 30 | $1,196 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $392 | $1,514,01355 claims |
| AbbVieRinvoq, Linzess | $998 | $117,07439 claims |
| Braintree Laboratories, Inc.Sutab | $75 | $3,33421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 935 gastroenterology providers in Pennsylvania.
Other gastroenterology in Pittsburgh
- Miguel RegueiroPittsburgh$1.5M
- Sandra El-HachemPittsburgh$472K
- Elie AounPittsburgh$323K
- Gursimran KochharPittsburgh$217K
- Michael BabichPittsburgh$157K
- Heitham Abdul-BakiPittsburgh$92K
- Katie FarahPittsburgh$55K
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Harshit KharaDanville$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.